Guido Rindi mostly deals with Internal medicine, Neuroendocrine tumors, Pathology, Endocrinology and Carcinoma. He combines subjects such as Gastroenterology and Oncology with his study of Internal medicine. Guido Rindi interconnects Stage and Surgery in the investigation of issues within Gastroenterology.
His research integrates issues of Who classification, Foregut, Somatostatin receptor, Somatostatin and Radiology in his study of Neuroendocrine tumors. His work deals with themes such as Pancreas and Endocrine system, which intersect with Pathology. His Endocrinology research is multidisciplinary, incorporating elements of University hospital, Well differentiated, Diagnostic accuracy, Chromogranin A and Gastric mucosa.
His primary scientific interests are in Internal medicine, Pathology, Neuroendocrine tumors, Endocrinology and Pancreas. His biological study spans a wide range of topics, including Gastroenterology and Oncology. His Pathology study combines topics in areas such as Adenocarcinoma, Lung and Endocrine system.
His study in Neuroendocrine tumors is interdisciplinary in nature, drawing from both Grading, Cancer research and Surgery. His studies deal with areas such as Cholecystokinin and Gastric mucosa as well as Endocrinology. The Enteroendocrine cell study which covers Enterochromaffin-like cell that intersects with Atrophic gastritis.
Guido Rindi mainly investigates Internal medicine, Neuroendocrine tumors, Pathology, Oncology and In patient. He has included themes like Gastroenterology and Surgery in his Internal medicine study. His Gastroenterology research incorporates themes from Relative risk, Progressive disease and Hazard ratio.
His studies in Neuroendocrine tumors integrate themes in fields like Grading, Neoplasm Grading, Ampulla and Tumor burden. His Pathology research focuses on Adenocarcinoma and how it relates to Lung. The various areas that Guido Rindi examines in his Oncology study include Cancer, Pancreas, Cohort and Endocrine system.
Guido Rindi focuses on Neuroendocrine tumors, Internal medicine, Pathology, World health and Radiology. Neuroendocrine tumors is a primary field of his research addressed under Endocrinology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
His Gastroenterology research includes themes of Body mass index, Surgery, Somatostatin and Hazard ratio. Many of his studies on Pathology involve topics that are commonly interrelated, such as Cell. His work on Biopsy, Contrast-enhanced ultrasound and Ultrasound as part of general Radiology research is frequently linked to Carotid endarterectomy, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gastroenteropancreatic neuroendocrine tumours.
Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen.
Lancet Oncology (2008)
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
G. Rindi;G. Klöppel;H. Alhman;M. Caplin.
Virchows Archiv (2006)
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Martyn E. Caplin;Marianne Pavel;Jarosław B. Ćwikła;Alexandria T. Phan.
The New England Journal of Medicine (2014)
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
G. Rindi;G. Klöppel;A. Couvelard;P. Komminoth.
Virchows Archiv (2007)
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study
Guido Rindi;Ombretta Luinetti;Matteo Cornaggia;Carlo Capella.
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
M. Falconi;B. Eriksson;G. Kaltsas;D.K. Bartsch.
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).
U. Plöckinger;G. Rindi;R. Arnold;B. Eriksson.
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
K. Öberg;L. Kvols;M. Caplin;G. Delle Fave.
Annals of Oncology (2004)
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.
G Rindi;C Bordi;S Rappel;S La Rosa.
World Journal of Surgery (1996)
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
Guido Rindi;M Falconi;C Klersy;L Albarello.
Journal of the National Cancer Institute (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: